生物制药
控制(管理)
透视图(图形)
生化工程
订单(交换)
业务
计算机科学
工程类
生物技术
人工智能
财务
生物
作者
Klaus Wuchner,Linda Yi,Cyrille C. Chéry,Felix Nikels,Friederike Junge,George Crotts,Gianluca Rinaldi,Jason A. Starkey,Karoline Bechtold-Peters,Melissa Shuman,Michael Leiß,Michael Jahn,Patrick Garidel,Rien de Ruiter,Sarah M. Richer,Shawn Cao,Sebastian Peuker,Sylvain Huille,Tingting Wang,Virginie Le Brun
标识
DOI:10.1016/j.xphs.2022.08.021
摘要
Polysorbate (PS) 20 and 80 are the main surfactants used to stabilize biopharmaceutical products. Industry practices on various aspects of PS based on a confidential survey and following discussions by 16 globally acting major biotechnology companies is presented in two publications. Part 1 summarizes the current practice and use of PS during manufacture in addition to aspects like current understanding of the (in)stability of PS, the routine QC testing and control of PS, and selected regulatory aspects of PS.1 The current part 2 of the survey focusses on understanding, monitoring, prediction, and mitigation of PS degradation pathways in order to propose an effective control strategy. The results of the survey and extensive cross-company discussions are put into relation with currently available scientific literature.
科研通智能强力驱动
Strongly Powered by AbleSci AI